GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenwich LifeSciences Inc (NAS:GLSI) » Definitions » Price-to-Tangible-Book

GLSI (Greenwich LifeSciences) Price-to-Tangible-Book : 90.91 (As of Jun. 25, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Greenwich LifeSciences Price-to-Tangible-Book?

As of today (2025-06-25), Greenwich LifeSciences's share price is $9.00. Greenwich LifeSciences's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was $0.10. Hence, Greenwich LifeSciences's Price to Tangible Book Ratio of today is 90.91.

The historical rank and industry rank for Greenwich LifeSciences's Price-to-Tangible-Book or its related term are showing as below:

GLSI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 6.38   Med: 15.17   Max: 96.36
Current: 90

During the past 7 years, Greenwich LifeSciences's highest Price to Tangible Book Ratio was 96.36. The lowest was 6.38. And the median was 15.17.

GLSI's Price-to-Tangible-Book is ranked worse than
98.75% of 1200 companies
in the Biotechnology industry
Industry Median: 2.89 vs GLSI: 90.00

A closely related ratio is called PB Ratio. As of today, Greenwich LifeSciences's share price is $9.00. Greenwich LifeSciences's Book Value per Sharefor the quarter that ended in Mar. 2025 was $0.10. Hence, Greenwich LifeSciences's P/B Ratio of today is 90.91.


Greenwich LifeSciences Price-to-Tangible-Book Historical Data

The historical data trend for Greenwich LifeSciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenwich LifeSciences Price-to-Tangible-Book Chart

Greenwich LifeSciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
Get a 7-Day Free Trial 16.78 11.93 14.79 20.19 58.19

Greenwich LifeSciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.23 38.36 37.92 58.19 96.36

Competitive Comparison of Greenwich LifeSciences's Price-to-Tangible-Book

For the Biotechnology subindustry, Greenwich LifeSciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenwich LifeSciences's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Greenwich LifeSciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Greenwich LifeSciences's Price-to-Tangible-Book falls into.


;
;

Greenwich LifeSciences Price-to-Tangible-Book Calculation

Greenwich LifeSciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2025 )
=9.00/0.099
=90.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Greenwich LifeSciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Greenwich LifeSciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenwich LifeSciences Business Description

Traded in Other Exchanges
N/A
Address
3992 Bluebonnet Drive, Building 14, Stafford, TX, USA, 77477
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
Executives
Snehal Patel director, officer: CHIEF EXECUTIVE OFFICER 2311 SPARTAN TRAIL, SUGAR LAND TX 77479
Jaye Thompson officer: VPC AND REGULATORY AFFAIRS 2408 TIMBERLOCH PLACE, B-7, THE WOODLANDS TX 77380
Frank Joseph Daugherty director, officer: CHIEF MEDICAL OFFICER 2311 SPARTAN TRAIL, SUGAR LAND TX 77479
Kenneth Hallock director 2311 SPARTAN TRAIL, SUGAR LAND TX 77479
David Mcwilliams director 2575 WEST BELLFORT STREET, HOUSTON TX 77054-9816
Eric Rothe director 2311 SPARTAN TRAIL, SUGAR LAND TX 77479
Kinnary Patel 10 percent owner 3992 BLUEBONNET DR., BUILDING 14, STAFFORD TX 77477
Panjaj Amrit Patel 10 percent owner 50726 LAKESIDE DRIVE, GRANGER IN 46530